Mutational landscape and clonal architecture in grade II and III gliomas. - Wikidata - awgldk - TriplyDB

Mutational landscape and clonal architecture in grade II and III gliomas.

Mutational landscape and clonal architecture in grade II and III gliomas.

http://www.wikidata.org/entity/Q41107185

about

Molecular Imaging of Metabolic Reprograming in Mutant IDH Cells Spatial genomic heterogeneity in diffuse intrinsic pontine and midline high-grade glioma: implications for diagnostic biopsy and targeted therapeutics Comprehensive, Integrative Genomic Analysis of Diffuse Lower-Grade Gliomas.IDH1 and IDH2 mutations as novel therapeutic targets: current perspectives Overcoming therapeutic resistance in glioblastoma: the way forward Oncogenic effects of evolutionarily conserved noncoding RNA ECONEXIN on gliomagenesis.Expression of lncRNAs in Low-Grade Gliomas and Glioblastoma Multiforme: An In Silico Analysis.BRAF V600E-mutated diffuse glioma in an adult patient: a case report and review.Salvage therapy with bendamustine for temozolomide refractory recurrent anaplastic gliomas: a prospective phase II trial.Genetic abnormalities in myelodysplasia and secondary acute myeloid leukemia: impact on outcome of stem cell transplantation Prospective Longitudinal Analysis of 2-Hydroxyglutarate Magnetic Resonance Spectroscopy Identifies Broad Clinical Utility for the Management of Patients With IDH-Mutant Glioma Comparative transcriptome analysis of isogenic cell line models and primary cancers links capicua (CIC) loss to activation of the MAPK signalling cascade Integrated genomic characterization of IDH1-mutant glioma malignant progression IDH mutant diffuse and anaplastic astrocytomas have similar age at presentation and little difference in survival: a grading problem for WHO.Introduction of High Throughput Magnetic Resonance T2-Weighted Image Texture Analysis for WHO Grade 2 and 3 Gliomas.Computational analysis of the mesenchymal signature landscape in gliomas.Segmentum: a tool for copy number analysis of cancer genomes.Isocitrate dehydrogenase mutations in gliomas PI3 kinase mutations and mutational load as poor prognostic markers in diffuse glioma patients TERT promoter mutations contribute to IDH mutations in predicting differential responses to adjuvant therapies in WHO grade II and III diffuse gliomas.IDH1 mutation detection by droplet digital PCR in glioma.Primary and recurrent diffuse astrocytomas: genomic profile comparison reveals acquisition of biologically relevant aberrations Intratumoral Heterogeneity of the Epigenome.ATRX mutations and glioblastoma: Impaired DNA damage repair, alternative lengthening of telomeres, and genetic instability.Detection of ATRX and IDH1-R132H immunohistochemistry in the progression of 211 paired gliomas CIMT 2015: The right patient for the right therapy - Report on the 13th annual meeting of the Association for Cancer Immunotherapy A combination of TERT promoter mutation and MGMT methylation status predicts clinically relevant subgroups of newly diagnosed glioblastomas.World Health Organization grade II-III astrocytomas consist of genetically distinct tumor lineages Multi-platform molecular profiling of a large cohort of glioblastomas reveals potential therapeutic strategies.Myc-Driven Glycolysis Is a Therapeutic Target in Glioblastoma.Recent advances and future of immunotherapy for glioblastoma.ATRX, IDH1-R132H and Ki-67 immunohistochemistry as a classification scheme for astrocytic tumors.Nuclear factor one B (NFIB) encodes a subtype-specific tumour suppressor in glioblastoma.Multiparametric MRI-based differentiation of WHO grade II/III glioma and WHO grade IV glioblastoma An immuno-wall microdevice exhibits rapid and sensitive detection of IDH1-R132H mutation specific to grade II and III gliomas Deferred radiotherapy and upfront procarbazine-ACNU-vincristine administration for 1p19q codeleted oligodendroglial tumors are associated with favorable outcome without compromising patient performance, regardless of WHO grade.Establishment of Anti-Human ATRX Monoclonal Antibody AMab-6.Co-expression modules of NF1, PTEN and sprouty enable distinction of adult diffuse gliomas according to pathway activities of receptor tyrosine kinases Genetic and epigenetic stability of oligodendrogliomas at recurrence.ATRX loss promotes tumor growth and impairs nonhomologous end joining DNA repair in glioma.

P2860

Q26750861-28F31688-A850-4FF4-BF45-43467F8D7963 Q27317083-2A16AAEF-6EF9-4105-9552-0C6F5EA74441 Q27853175-94ADCCEC-E4E2-416F-B227-3D732A6C9490 Q28066926-49CF74AD-04E9-42A9-A2DC-77F9C7AD61F8 Q29248396-364D7DEA-014E-4484-A439-7F5446144AAE Q30252747-92E30BB1-61F4-48B0-A03C-4681D8A2D025 Q30275293-F78967BF-E78E-4DAE-B1CA-8EBEBB74CCDA Q31002780-A01FFF79-7156-4623-88D2-282313EA346E Q33439379-DD9D2E51-E0DF-4E4C-BD5D-E0C7A3C9BC28 Q33615619-BF7C08A7-DAE7-4271-8300-3F2C6CBF2BFC Q33816600-24A849BB-77AB-43C4-AED2-6541470CB0B4 Q33835854-E67EDC9E-5FBA-4E50-9845-5D3C696AE8D1 Q34503475-940FE489-7111-476A-912C-E26035F8B466 Q35845197-6B73B6C1-ACA8-4359-8338-260001454FB9 Q36157713-9E87A5E9-1558-477D-83DD-E3F0AFABE801 Q36303247-01A9F969-0DA3-4928-8E32-944872657539 Q36346318-61AF1255-1298-4501-83AF-07CF11878F86 Q36367409-A5FBCF9E-E4E5-4CB2-8967-987181BD530B Q36402259-2049BD98-B718-4C8B-96DE-3DAD8C597A58 Q36413047-E04485DF-5D53-4973-AA8A-683EC1F0FDD3 Q36545444-34469C6A-135C-4955-B4ED-F0B9E13019BF Q36566055-8ECD3B40-EBB2-4C4B-ADD7-C79AA918CF90 Q36854908-27FF71B6-95C7-48AC-A405-1749D52FA058 Q37008597-85A1BF08-2CB2-4582-B441-A0620B6373A3 Q37086042-BAE12685-FF0D-446F-8517-E70921A8593F Q37130209-B6AD9E95-4681-429E-ACA8-429D9483E975 Q37160414-6F0764C2-9A61-420D-BE1C-46A2A9F1991A Q37170743-C979D7DB-97EC-414C-A100-A2B319E85247 Q37225334-31514319-C295-462E-A9FC-F984343F3F9F Q37230411-AE830217-68A2-437C-805D-0C9149C7E4CC Q37239071-3EFC6DA7-B0CD-4509-AAF9-AB3B42B09B3B Q37298192-D0FEBD97-2F89-445D-B55B-9329AE3D8F57 Q37301799-572444D4-7B34-48BD-9BA9-EFCC5AD4F1BF Q37339878-5A07D25B-C78A-4C8C-9E6F-C5B38F08EE69 Q37403150-39E7B75D-8050-4615-82F4-8606A6341966 Q37429161-CFE6E857-9847-4454-BA4F-02D599C85CE8 Q37509161-9FCCC7E3-657E-4499-AB71-2C5B7438DE3C Q37644826-A9F9285F-604D-4001-8E3C-8D5C6A653FBC Q37684236-E6C45677-403C-447D-B436-0911E9C2D1E2 Q37738658-37077CEB-BFD6-4C98-AFD6-994546C966F6

P2860

Mutational landscape and clonal architecture in grade II and III gliomas.

http://www.wikidata.org/entity/Q41107185

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

2015年论文

@zh

2015年论文

@zh-cn

name

Mutational landscape and clonal architecture in grade II and III gliomas.

@en

type

label

Mutational landscape and clonal architecture in grade II and III gliomas.

@en

prefLabel

Mutational landscape and clonal architecture in grade II and III gliomas.

@en

P1433

Q41107185-BD03EF6D-0113-4717-9F77-3C2CE0B0FFEC

P1476

Q41107185-7220A37D-989A-4634-A8EF-625E67C3E36B

P2093

Q41107185-08D98125-6D65-4C21-85AF-F5930F3136B5

Q41107185-1129AAA1-F0D2-480F-897A-EA695FC766D3

Q41107185-11CDE0D5-373D-4484-8F90-8591A5852A4A

Q41107185-3D1C8B02-3CA6-4D8F-9BFF-4A2C7F5B5CFF

Q41107185-444E56E0-1CFC-44B7-95FC-7351A760A8E0

Q41107185-4968839A-A582-455F-B769-F79B8391E9D1

Q41107185-5268D1DB-076F-4DE4-B2D8-68606F06CF92

Q41107185-55BF9A77-4E31-4F1C-91B5-DCD41507E314

Q41107185-631EFF3D-0BAF-4A22-9DE2-46F90E20391A

Q41107185-7388E97C-2899-4F15-881E-804389BA8827

P2888

Q41107185-BB5A6670-A758-4B5A-901E-34C39218DD4E

P304

Q41107185-88C4170A-D669-4A5D-996A-B976DABCB8BA

P31

Q41107185-5A07D54E-2BF8-4D92-80E9-213514E9F37F

P356

Q41107185-A5A322DF-4EC5-4183-B89A-3B0AE089B39D

P407

Q41107185-38D63A8F-3E71-4E40-AE8B-7B187AB1882F

P433

Q41107185-1B97BEA5-7F56-438B-A185-F4EA6613E75D

P478

Q41107185-ABB4C6A5-09E4-4FD6-A67E-9758C84D2051

P50

Q41107185-1A1D93E2-B64F-400A-9F36-8AD70A6EFFEE

Q41107185-A94F4119-8650-4FF4-99CB-F954D57E956F

Q41107185-BE3F1AA1-0AC8-486B-84CC-0B7EB33FCEA5

P577

Q41107185-722D80C5-CDFA-4F8A-AF21-22BF676C2C28

P5875

Q41107185-5DF4E389-9013-41FB-8A6C-55B5F4F30F38

P6179

Q41107185-B4C43E28-EC1E-4CE2-ACED-31999EA42CA9

P698

Q41107185-68CD531F-E24A-4443-A638-F36C31B55490

P356

P1433

Nature Genetics

P1476

Mutational landscape and clonal architecture in grade II and III gliomas.

@en

P2093

Aiko Sato-Otsubo

http://www.w3.org/2001/XMLSchema#string

Atsushi Natsume

http://www.w3.org/2001/XMLSchema#string

Atsushi Niida

http://www.w3.org/2001/XMLSchema#string

Fumiharu Ohka

http://www.w3.org/2001/XMLSchema#string

Hideo Nakamura

http://www.w3.org/2001/XMLSchema#string

Hiroko Tanaka

http://www.w3.org/2001/XMLSchema#string

Hiromichi Suzuki

http://www.w3.org/2001/XMLSchema#string

Ichiro Ito

http://www.w3.org/2001/XMLSchema#string

Kazuya Motomura

http://www.w3.org/2001/XMLSchema#string

Keisuke Kataoka

http://www.w3.org/2001/XMLSchema#string

P2888

P304

458-468

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/NG.3273

http://www.w3.org/2001/XMLSchema#string

P407

P433

5

http://www.w3.org/2001/XMLSchema#string

P478

47

http://www.w3.org/2001/XMLSchema#string

P50

Teppei Shimamura

Kenichi Yoshida

Tetsuichi Yoshizato

P577

2015-04-13T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

274643961

http://www.w3.org/2001/XMLSchema#string

P6179

1007363870

http://www.w3.org/2001/XMLSchema#string

P698

25848751

http://www.w3.org/2001/XMLSchema#string